• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,266.08 1,433.53
( 1.94%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524632
INE551C01044
2.051431
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
58.32
1276.86
EPS(TTM)
Face Value()
Div & Yield %
0.5
1
0.03
 

J&K Bank gains as gross advances grow 17% YoY in Q4 FY26
Apr 06,2026
Total business stood at Rs 290,340.57 crore as of 31 March 2026, up 13.61%, compared with Rs 255,554.95 crore as of 31 March 2025.

Total deposits increased 11.30% to Rs 165,354.04 crore as of 31 March 2026, compared with Rs 148,569.46 crore as of 31 March 2025. CASA deposits rose 8.07% YoY to Rs 75,478.40 crore as of 31 March 2026.

Gross investment declined 1.55% to Rs 41,319.50 crore as of 31 March 2026, compared with Rs 41,970.20 crore as of 31 March 2025.

J&K Bank offers banking services under the three major divisions as support services, depository services, and third-party services.

The bank reported a 10.4% jump in net profit to Rs 586.73 crore on a 4.2% rise in total income to Rs 3,592.90 crore in Q3 FY26 over Q3 FY25.